Concurrent nitroglycerin administration reduces the efficacy of recombinant tissue-type plasminogen activator in patients with acute anterior wall myocardial infarction.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 7572574)

Published in Am Heart J on October 01, 1995

Authors

F Romeo1, G M Rosano, E Martuscelli, F De Luca, C Bianco, C Colistra, M Comito, N Cardona, F Miceli, V Rosano

Author Affiliations

1: Department of Cardiology, University of Rome, Italy.

Articles citing this

Concomitant nitroglycerin and rTPA. Am Heart J (1997) 0.75

Articles by these authors

(truncated to the top 100)

A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86

Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med (1975) 7.87

Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67

Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood (1973) 4.99

Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med (1981) 3.93

Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G. J Exp Med (1975) 3.80

Theta-bearing and complement-receptor lymphocytes are distinct populations of cells. Science (1971) 3.16

Mechanism of binding of soluble immune complexes to lymphocytes. Cell Immunol (1973) 2.93

Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89

Studies on the selective lysis and purification of Trypanosoma cruzi. J Exp Med (1975) 2.54

Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation (1995) 2.49

The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med (1976) 2.41

Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A (1970) 2.29

Evaluation of mosaic pattern areas in HRCT with Min-IP reconstructions in patients with pulmonary hypertension: could this evaluation replace lung perfusion scintigraphy? Eur J Radiol (2010) 2.27

Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia. Blood (1972) 2.25

Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80

Hypertrophic cardiomyopathy: is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J (1990) 1.73

Copper induction of laccase isoenzymes in the ligninolytic fungus Pleurotus ostreatus. Appl Environ Microbiol (2000) 1.69

Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer (2003) 1.67

Immune phagocytosis in murine malaria. J Exp Med (1979) 1.66

The ErbB receptors and their ligands in cancer: an overview. Curr Drug Targets (2005) 1.59

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy (2001) 1.56

A novel white laccase from Pleurotus ostreatus. J Biol Chem (1997) 1.52

The induction of macrophage spreading by factor B of the properdin system. J Exp Med (1979) 1.50

Analysis of genetic variability within Thelazia callipaeda (Nematoda: Thelazioidea) from Europe and Asia by sequencing and mutation scanning of the mitochondrial cytochrome c oxidase subunit 1 gene. Mol Cell Probes (2005) 1.50

Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46

The role of EGF-related peptides in tumor growth. Front Biosci (2001) 1.45

Complement receptors. Contemp Top Mol Immunol (1977) 1.44

Hormone replacement therapy: where we stand in Europe. Eur Heart J (2001) 1.44

TTF-2/FOXE1 gene polymorphisms in Sicilian patients with permanent primary congenital hypothyroidism. J Endocrinol Invest (2007) 1.42

Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res (1997) 1.37

Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion (1985) 1.36

Autopsy findings in 111 cases of esophageal cancer. Cancer (1981) 1.34

Regulation of macrophage migration by products of the complement system. Proc Natl Acad Sci U S A (1979) 1.29

C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol (1973) 1.28

A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation. Cell Immunol (1971) 1.27

Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. Clin Immunol Immunopathol (1973) 1.27

Characterization and Sequence Variation in the rDNA Region of Six Nematode Species of the Genus Longidorus (Nematoda). J Nematol (2004) 1.25

Monocyte receptors for fibronectin characterized by a monoclonal antibody that interferes with receptor activity. J Exp Med (1985) 1.25

Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American children. Diabetes Care (2001) 1.23

The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22

Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology (1998) 1.22

Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol (2008) 1.16

Interaction and release of soulble immune complexes from mouse B luymphocytes. Cell Immunol (1973) 1.14

Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst (1996) 1.13

Fibronectin receptors of mononuclear phagocytes: binding characteristics and biochemical isolation. Exp Cell Res (1989) 1.11

Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60. Blood (1984) 1.10

Plasma membrane polypeptides of resident and activated mouse peritoneal macrophages. Proc Natl Acad Sci U S A (1980) 1.10

Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium. Biol Reprod (2001) 1.09

Antibody-mediated cell cytotoxicity in a defined system: regulation by antigen, antibody, and complement. J Immunol (1976) 1.09

Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system. Am J Cardiol (2000) 1.09

Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem (1997) 1.08

Expression of transforming growth factor alpha (TGF alpha) in breast cancer. Ann Oncol (1991) 1.08

Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management. Liver (1996) 1.07

Longitudinal study of blood pressure during the 1st year of life. Eur J Pediatr (1990) 1.06

Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet (1996) 1.06

Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. Exp Cell Res (2001) 1.05

Hypoglycaemia and congenital adrenal hyperplasia. Acta Paediatr Scand (1979) 1.04

Specific binding of the human monocytic cell line U937 to the alternatively spliced connecting segment (IIICS) of fibronectin. J Exp Med (1990) 1.04

Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders. J Endocrinol Invest (1983) 1.02

Cardiovascular protection by oestrogen--a calcium antagonist effect? Lancet (1993) 1.00

The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene (1997) 1.00

Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. Cancer Res (1999) 1.00

Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatr Res (2000) 0.99

Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion (1994) 0.99

Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile. Clin Vaccine Immunol (2009) 0.99

Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol (2003) 0.99

Deferral of males who had sex with other males. Vox Sang (2011) 0.98

Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice. J Pathol (2007) 0.98

Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion (2005) 0.98

RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer (2000) 0.97

Purification, characterization, and functional role of a novel extracellular protease from Pleurotus ostreatus. Appl Environ Microbiol (2001) 0.96

Activation of C3H/HeJ macrophages by endotoxin. J Immunol (1980) 0.96

Fibrin, fibronectin, and macrophages. Ann N Y Acad Sci (1983) 0.95

Obesity in a child with untreated coeliac disease. Helv Paediatr Acta (1987) 0.95

Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol (1998) 0.95

Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol (1999) 0.94

Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat (2001) 0.94

Liver glycogenosis as early manifestation in type 1 diabetes mellitus. Diabetes Nutr Metab (2003) 0.94

Physico-chemical surface characterization of hyaluronic acid derivatives as a new class of biomaterials. J Biomater Sci Polym Ed (1993) 0.93

Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays (1999) 0.93

Pulmonary trunk stenosis due to constriction by a pericardial band. Am Heart J (1987) 0.93

Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway. Cell Growth Differ (1997) 0.92

Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood (1996) 0.92

Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. Bone Marrow Transplant (2006) 0.91

Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab (2002) 0.91

[Agenesis of the gallbladder. Description of 2 cases in 2 siblings]. Pediatr Med Chir (1990) 0.90

Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development. J Endocrinol Invest (2006) 0.89

Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene (1994) 0.89

Transfusion-associated transmission of babesiosis in New York State. Transfusion (2000) 0.89

Idiopathic hypercalciuria with bilateral macular colobomata: a new variant of oculo-renal syndrome. Helv Paediatr Acta (1979) 0.89

Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab (1999) 0.89

Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients. Heart (2002) 0.89

Cardiac treatment in neuro-muscular diseases. Acta Myol (2006) 0.88

Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels. Pharmacol Res (2013) 0.88

Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients. Clin Microbiol Infect (2012) 0.88

Diagnosis and Molecular Variability of an Argentinean Population of Nacobbus aberrans with Some Observations on Histopathology in Tomato. J Nematol (2007) 0.88

Subclinical hypothyroidism: the state of the art. J Endocrinol Invest (2008) 0.88

Eosinophilic pancreatitis in the newborn infant of a diabetic mother. Virchows Arch A Pathol Anat Histol (1978) 0.88